Literature DB >> 24652792

Functional role of glucose metabolism, osmotic stress, and sodium-glucose cotransporter isoform-mediated transport on Na+/H+ exchanger isoform 3 activity in the renal proximal tubule.

Thaissa Dantas Pessoa1, Luciene Cristina Gastalho Campos2, Luciene Carraro-Lacroix3, Adriana C C Girardi2, Gerhard Malnic4.   

Abstract

Na(+)-glucose cotransporter 1 (SGLT1)-mediated glucose uptake leads to activation of Na(+)-H(+) exchanger 3 (NHE3) in the intestine by a process that is not dependent on glucose metabolism. This coactivation may be important for postprandial nutrient uptake. However, it remains to be determined whether SGLT-mediated glucose uptake regulates NHE3-mediated NaHCO3 reabsorption in the renal proximal tubule. Considering that this nephron segment also expresses SGLT2 and that the kidneys and intestine show significant variations in daily glucose availability, the goal of this study was to determine the effect of SGLT-mediated glucose uptake on NHE3 activity in the renal proximal tubule. Stationary in vivo microperfusion experiments showed that luminal perfusion with 5 mM glucose stimulates NHE3-mediated bicarbonate reabsorption. This stimulatory effect was mediated by glycolytic metabolism but not through ATP production. Conversely, luminal perfusion with 40 mM glucose inhibited NHE3 because of cell swelling. Notably, pharmacologic inhibition of SGLT activity by Phlorizin produced a marked inhibition of NHE3, even in the absence of glucose. Furthermore, immunofluorescence experiments showed that NHE3 colocalizes with SGLT2 but not SGLT1 in the rat renal proximal tubule. Collectively, these findings show that glucose exerts a bimodal effect on NHE3. The physiologic metabolism of glucose stimulates NHE3 transport activity, whereas, supraphysiologic glucose concentrations inhibit this exchanger. Additionally, Phlorizin-sensitive SGLT transporters and NHE3 interact functionally in the proximal tubule.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24652792      PMCID: PMC4147971          DOI: 10.1681/ASN.2013060588

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  66 in total

1.  Evidence for involvement of the putative first extracellular loop in differential volume sensitivity of the Na+/H+ exchangers NHE1 and NHE2.

Authors:  Xiaohua Su; Tianxiang Pang; Shigeo Wakabayashi; Munekazu Shigekawa
Journal:  Biochemistry       Date:  2003-02-04       Impact factor: 3.162

2.  Ezrin regulates NHE3 translocation and activation after Na+-glucose cotransport.

Authors:  Huiren Zhao; Harn Shiue; Sara Palkon; Yingmin Wang; Patrick Cullinan; Janis K Burkhardt; Mark W Musch; Eugene B Chang; Jerrold R Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

3.  Role of dipeptidyl peptidase IV in regulating activity of Na+/H+ exchanger isoform NHE3 in proximal tubule cells.

Authors:  Adriana C C Girardi; Felix Knauf; Hans-Ulrich Demuth; Peter S Aronson
Journal:  Am J Physiol Cell Physiol       Date:  2004-06-22       Impact factor: 4.249

4.  The compartmentation of glycolytic and gluconeogenic enzymes in rat kidney and liver and its significance to renal and hepatic metabolism.

Authors:  G M Lawrence; M A Jepson; I P Trayer; D G Walker
Journal:  Histochem J       Date:  1986-01

5.  Depletion of cellular ATP inhibits Na+/H+ antiport in cultured human cells. Modulation of the regulatory effect of intracellular protons on the antiporter activity.

Authors:  D Cassel; M Katz; M Rotman
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

6.  Branched-chain amino acid aminotransferase along the rabbit and rat nephron.

Authors:  H B Burch; N Cambon; O H Lowry
Journal:  Kidney Int       Date:  1985-08       Impact factor: 10.612

Review 7.  Enzyme distribution along the nephron.

Authors:  W G Guder; B D Ross
Journal:  Kidney Int       Date:  1984-08       Impact factor: 10.612

8.  Dependence of Na+/H+ antiport activation in cultured rat aortic smooth muscle on calmodulin, calcium, and ATP. Evidence for the involvement of calmodulin-dependent kinases.

Authors:  P J Little; P L Weissberg; E J Cragoe; A Bobik
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

Review 9.  The sodium/glucose cotransport family SLC5.

Authors:  Ernest M Wright; Eric Turk
Journal:  Pflugers Arch       Date:  2003-05-14       Impact factor: 3.657

10.  The pH of spontaneously beating cultured rat heart cells is regulated by an ATP-calmodulin-dependent Na+/H+ antiport.

Authors:  P L Weissberg; P J Little; E J Cragoe; A Bobik
Journal:  Circ Res       Date:  1989-04       Impact factor: 17.367

View more
  55 in total

Review 1.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

Review 2.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

3.  Unmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat.

Authors:  Takahiro Masuda; Yuko Watanabe; Keiko Fukuda; Minami Watanabe; Akira Onishi; Ken Ohara; Toshimi Imai; Hermann Koepsell; Shigeaki Muto; Volker Vallon; Daisuke Nagata
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-23

4.  Hypotonic Stress-induced Down-regulation of Claudin-1 and -2 Mediated by Dephosphorylation and Clathrin-dependent Endocytosis in Renal Tubular Epithelial Cells.

Authors:  Naoko Fujii; Yukinobu Matsuo; Toshiyuki Matsunaga; Satoshi Endo; Hideki Sakai; Masahiko Yamaguchi; Yasuhiro Yamazaki; Junko Sugatani; Akira Ikari
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

Review 5.  SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases.

Authors:  Christoph Wanner; Nikolaus Marx
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

Review 6.  Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.

Authors:  David León Jiménez; David Z I Cherney; Petter Bjornstad; Luis Castilla-Guerra; José Pablo Miramontes González
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-01

7.  A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin.

Authors:  Akira Onishi; Yiling Fu; Rohit Patel; Manjula Darshi; Maria Crespo-Masip; Winnie Huang; Panai Song; Brent Freeman; Young Chul Kim; Manoocher Soleimani; Kumar Sharma; Scott Culver Thomson; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-07

Review 8.  Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Diabetologia       Date:  2016-11-22       Impact factor: 10.122

Review 9.  Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.

Authors:  Milton Packer
Journal:  J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 10.121

Review 10.  Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update.

Authors:  Aleksandra Novikov; Volker Vallon
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.